1
Healthy Donor & NK Cells
Source Screening • Traceability
HOME>About Us
- Vesicle Research Using Materials from Different Sources
- Extracellular Vesicle Quality and Process Development Research
- NK-EV R&D and Manufacturing Platform
- About Us
- Research Team
- Pipeline
- Understanding Exosomes
- World’s Only | PHP999® Plant Exosome Ingredient
- The Exosome Era of Wealth Creation Has Arrived
- Core Competencies and Competitive Advantages
- Revolutionary Applications of Exosomes
NK-EV R&D and Manufacturing Platform
NK-EV
R&D & Production Platform
TEC-NKEXO
Natural Non-Genetically Modified NK Cell-Derived Extracellular Vesicles
Healthy Donor
Primary NK Cells
Cell-Free Formulation
01
Production Platform
Existing Process & Formulation Development
2
NK Cell Expansion
Cell Count • Purity • Activity
3
EV Collection & Purification
Culture Supernatant → TFF / SEC
4
Formulation & Lyophilization
Filling • Storage Condition Assessment
02
Quality Strategy
Analytical Items & Validation Directions
Physics & Identity
NTA Particle Size / Concentration • CD9 / CD63 / CD81
Function & Safety
Podocyte Protection Potency • Sterility / Endotoxin / Residues
Consistency & Stability
Batch Comparison • Cargo Loading Analysis • Lyophilized Storage & Potency Tracking
03
Nephrology R&D
Lupus Nephritis (LN)
Core Development Direction
Preclinical Research Signals
Improvement in Proteinuria and Renal Function Indicators
Improved Nephrin / ZO-1 Expression
Improved Nephrin / ZO-1 Expression
Extended Exploration: AKI → CKD • Renal Fibrosis
04
Translational Pathway
Next-Stage Goals
Potency & Batch Validation
GLP Toxicology
CMC Scale-Up
IND Preparation